Deutsche Bank Ag\ Werewolf Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.48 - $3.63 $123,094 - $301,914	83,172 Added 450.7%	101,626 $150,000
Q3 2024 Jun 26, 2025	SELL	$1.71 - $2.95 $142,224 - $245,357	-83,172 Reduced 81.84%	18,454 $39,000
Q3 2024 Nov 13, 2024	BUY	$1.71 - $2.95 $31,556 - $54,439	18,454 New	18,454 $39,000
Q2 2022 Aug 11, 2022	SELL	$3.43 - $5.98 $49,217 - $85,807	-14,349 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$3.71 - $12.22 $6,299 - $20,749	-1,698 Reduced 10.58%	14,349 $63,000
Q4 2021 Feb 11, 2022	BUY	$11.48 - $17.65 $134,270 - $206,434	11,696 Added 268.81%	16,047 $191,000
Q3 2021 Nov 04, 2021	SELL	$13.89 - $20.31 $1,958 - $2,863	-141 Reduced 3.14%	4,351 $75,000
Q2 2021 Aug 11, 2021	BUY	$11.6 - $17.44 $52,107 - $78,340	4,492 New	4,492 $78,000

23.6M

Ticker HOWL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,529,400
Market Cap $35.4M
Description
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.